Relevance of Hepatitis B Virus Genome Variability in Organ Transplantation

Hepatitis B virus (HBV) can cause acute and chronic hepatitis in humans, with the latter possibly leading to liver cirrhosis and hepatocellular carcinoma. The clinical course of HBV infection is critically dependent on genetic and immune features of the host as well as on virological factors. In situations of immune suppression, e.g. in patients after organ transplantation with chronic HBV infection, severe progression of liver disease can occur, due to direct effects of immunosuppressive regimens on HBV's hepatotoxicity or replication and due to the selection of HBV mutants. HBV variants are commonly found in chronically infected patients because of the lack of proofreading capacity of the HBV reverse transcriptase. Examples of relevant HBV mutations include precore or basal core promoter mutants with increased replication capacity, escape mutants with alterations in the 'a-determinant' immune epitope, core gene deletions after renal transplantation, antiviral drug resistant strains and accumulation of complex HBV variants after long-term immune suppression. In this review, we present the virological background of HBV genetic variability, discuss frequent mutations observed in transplanted patients and address the effects of HBV genetic variability on the clinical

[1]  V. Bruss Hepatitis B virus morphogenesis. , 2007, World journal of gastroenterology.

[2]  S. Schaefer,et al.  Hepatitis B virus taxonomy and hepatitis B virus genotypes. , 2007, World journal of gastroenterology.

[3]  F. von Weizsäcker,et al.  Pathogenesis of hepatitis B virus infection. , 2007, World journal of gastroenterology.

[4]  C. Mazzucco,et al.  Entecavir resistance is rare in nucleoside naïve patients with hepatitis B , 2006, Hepatology.

[5]  F. Zoulim Hepatitis B virus resistance to entecavir in nucleoside naïve patients: Does it exist? , 2006, Hepatology.

[6]  R. Gish,et al.  Hepatitis B in liver transplant recipients , 2006, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[7]  J. Villeneuve,et al.  Selection of a multiple drug-resistant hepatitis B virus strain in a liver-transplanted patient. , 2006, Gastroenterology.

[8]  G. Kristiansen,et al.  Functional analysis of complex hepatitis B virus variants associated with development of liver cirrhosis. , 2006, Gastroenterology.

[9]  Roger Williams Global challenges in liver disease , 2006, Hepatology.

[10]  S. Locarnini,et al.  Antiviral drug resistance: clinical consequences and molecular aspects. , 2006, Seminars in liver disease.

[11]  S. Lewin,et al.  Immunopathogenesis: Role of Innate and Adaptive Immune Responses , 2006, Seminars in liver disease.

[12]  T. Harrison,et al.  Hepatitis B Virus: Molecular Virology and Common Mutants , 2006, Seminars in liver disease.

[13]  Angeline Bartholomeusz,et al.  HBV drug resistance: mechanisms, detection and interpretation. , 2006, Journal of hepatology.

[14]  A. Lok,et al.  Natural history of chronic hepatitis B virus infection: What we knew in 1981 and what we know in 2005 , 2006, Hepatology.

[15]  T. Wright Introduction to Chronic Hepatitis B Infection , 2006, The American Journal of Gastroenterology.

[16]  S. Locarnini,et al.  Hepatitis B virus mutations associated with antiviral therapy , 2006, Journal of medical virology.

[17]  M. Alter,et al.  Epidemiology of viral hepatitis and HIV co-infection. , 2006, Journal of hepatology.

[18]  G. Cirillo,et al.  Heart transplantation in patients with chronic hepatitis B: clinical evolution, molecular analysis, and effect of treatment. , 2005, Transplantation.

[19]  Shu-sen Zheng,et al.  Hepatitis B virus reinfection after liver transplantation: related risk factors and perspective. , 2005, Hepatobiliary & pancreatic diseases international : HBPD INT.

[20]  A. Frodsham Host genetics and the outcome of hepatitis B viral infection. , 2005, Transplant immunology.

[21]  B. Rehermann,et al.  Immunology of hepatitis B virus and hepatitis C virus infection , 2005, Nature Reviews Immunology.

[22]  P. Colson,et al.  Fulminant hepatitis B associated with a specific insertion in the basal core promoter region of hepatitis B virus DNA after immunosuppressive treatment. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[23]  B. Weber Genetic variability of the S gene of hepatitis B virus: clinical and diagnostic impact. , 2005 .

[24]  S. Dourakis,et al.  Genetic heterogeneity of hepatitis viruses and its clinical significance. , 2005, Current drug targets. Inflammation and allergy.

[25]  S. Locarnini Molecular virology and the development of resistant mutants: implications for therapy. , 2005, Seminars in liver disease.

[26]  M. Manns,et al.  Influence of mutations in the hepatitis B virus genome on virus replication and drug resistance--implications for novel antiviral strategies. , 2004, Current medicinal chemistry.

[27]  C. Trautwein Mechanisms of hepatitis B virus graft reinfection and graft damage after liver transplantation. , 2004, Journal of hepatology.

[28]  T. Luedde,et al.  Basal Core Promoter and Precore Mutations in the Hepatitis B Virus Genome Enhance Replication Efficacy of Lamivudine-Resistant Mutants , 2004, Journal of Virology.

[29]  S. Locarnini Molecular virology of hepatitis B virus. , 2004, Seminars in liver disease.

[30]  F. Fabrizi,et al.  HBV Infection in Patients With End-Stage Renal Disease , 2004, Seminars in liver disease.

[31]  M. Manns,et al.  Relevance of hepatitis B core gene deletions in patients after kidney transplantation. , 2003, Gastroenterology.

[32]  N. Moolla,et al.  Regulatory elements of hepatitis B virus transcription , 2002, Journal of viral hepatitis.

[33]  Jin-Hwang Liu,et al.  Detection of reactivation and genetic mutations of the hepatitis B virus in patients with chronic hepatitis B infections receiving hematopoietic stem cell transplantation1 , 2002, Transplantation.

[34]  S. Günther,et al.  Complex HBV populations with mutations in core promoter, C gene, and pre‐S region are associated with development of cirrhosis in long‐term renal transplant recipients , 2002, Hepatology.

[35]  M. Manns,et al.  Cross-Resistance Testing of Antihepadnaviral Compounds Using Novel Recombinant Baculoviruses Which Encode Drug-Resistant Strains of Hepatitis B Virus , 2001, Antimicrobial Agents and Chemotherapy.

[36]  S. Günther,et al.  Enhanced replication contributes to enrichment of hepatitis B virus with a deletion in the core gene. , 2000, Virology.

[37]  A. Zuckerman Effect of hepatitis B virus mutants on efficacy of vaccination , 2000, The Lancet.

[38]  H. Thomas,et al.  Effect of variation in the common “a” determinant on the antigenicity of hepatitis B surface antigen , 2000, Journal of medical virology.

[39]  M. Kew,et al.  The core promoter of hepatitis B virus , 1999, Journal of viral hepatitis.

[40]  S. Günther,et al.  Hepatitis B virus genomes from long-term immunosuppressed virus carriers are modified by specific mutations in several regions. , 1999, The Journal of general virology.

[41]  P. Reinke,et al.  Disappearance of hepatitis B virus core deletion mutants and successful combined kidney/liver transplantation in a patient treated with lamivudine , 1999, Transplant International.

[42]  L. Stuyver,et al.  Three cases of severe subfulminant hepatitis in heart‐transplanted patients after nosocomial transmission of a mutant hepatitis B virus , 1999, Hepatology.

[43]  P Coriat,et al.  Impact of hepatitis B and C virus on kidney transplantation outcome , 1999, Hepatology.

[44]  A. Lok,et al.  Hepatitis B virus S mutants in liver transplant recipients who were reinfected despite hepatitis B immune globulin prophylaxis , 1998, Hepatology.

[45]  S. Günther,et al.  Hepatitis B virus sequence changes evolving in liver transplant recipients with fulminant hepatitis. , 1997, Journal of hepatology.

[46]  S. Günther,et al.  Association between the accumulation of hepatitis B virus core gene deletion mutants and progression of liver disease in long-term renal transplant patients. , 1997, Transplantation proceedings.

[47]  S. Günther,et al.  Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease , 1996, Journal of virology.

[48]  P. Angus,et al.  Mutations in the hepatitis B virus precore/core gene and core promoter in patients with severe recurrent disease following liver transplantation , 1996 .

[49]  S. Günther,et al.  Accumulation and persistence of hepatitis B virus core gene deletion mutants in renal transplant patients are associated with end‐stage liver disease , 1996, Hepatology.

[50]  M. Manns,et al.  Hepatitis B virus envelope variation after transplantation with and without hepatitis B immune globulin prophylaxis , 1996, Hepatology.

[51]  S. Kubicka,et al.  Hepatitis B virus mutations in the pre‐S genome before and after liver transplantatio , 1996, Hepatology.

[52]  H. Okamoto,et al.  A common-source outbreak of fulminant hepatitis B in hemodialysis patients induced by precore mutant. , 1995, Kidney international.

[53]  P. Angus,et al.  Hepatitis B virus precore mutant infection is associated with severe recurrent disease after liver transplantation , 1995, Hepatology.

[54]  F. Chisari,et al.  Hepatitis B virus immunopathogenesis. , 1995, Annual review of immunology.

[55]  S. Durrant,et al.  Fatal Reactivation of Precore Mutant Hepatitis B Virus Associated with Fibrosing Cholestatic Hepatitis after Bone Marrow Transplantation , 1994, Annals of Internal Medicine.

[56]  H. Thomas,et al.  MUTATION PREVENTING FORMATION OF HEPATITIS B e ANTIGEN IN PATIENTS WITH CHRONIC HEPATITIS B INFECTION , 1989, The Lancet.

[57]  L. Poellinger,et al.  The glucocorticoid receptor recognizes a specific nucleotide sequence in hepatitis B virus DNA causing increased activity of the HBV enhancer. , 1988, Virology.

[58]  P. Tiollais,et al.  Hepatitis B virus. , 1991, Scientific American.

[59]  R. Burk,et al.  Hepatitis B virus DNA contains a glucocorticoid-responsive element. , 1986, Proceedings of the National Academy of Sciences of the United States of America.